OBJECTIVE: Limited data exist on the quality of care for patients with venous thromboembolism (VTE), and it is unknown whether the processes and outcomes of care for this illness differ between African Americans and whites. STUDY DESIGN AND SETTING: We retrospectively studied 168 patients hospitalized for VTE in two Veterans Affairs hospitals during fiscal years 2000-2002. Patient characteristics, information about processes of care, and medical outcomes at 90 days after the index VTE event were abstracted from medical records. We used logistic regression to explore associations between race, processes of care, and the overall 90-day complication rate (i.e., death, bleeding, or recurrent VTE), adjusting for patient baseline characteristics. RESULTS: Multivariable analysis demonstrated that administration of warfarin within 1 day of starting heparin (odds ratio [OR] 0.20, 95% confidence interval [CI]: 0.05-0.42) and overlap of heparin and warfarin treatment >or=4 days (OR 0.09, 95% CI: 0.02-0.50) were associated with a lower complication rate, and African American race was associated with a higher complication rate (OR 5.2, 95% CI: 1.3-21.6). Race was not significantly associated with the performance of processes of care in multivariable analysis. CONCLUSION: Although African Americans had an increased risk of complications following VTE, race was not independently associated with the use of processes of care for VTE.
OBJECTIVE: Limited data exist on the quality of care for patients with venous thromboembolism (VTE), and it is unknown whether the processes and outcomes of care for this illness differ between African Americans and whites. STUDY DESIGN AND SETTING: We retrospectively studied 168 patients hospitalized for VTE in two Veterans Affairs hospitals during fiscal years 2000-2002. Patient characteristics, information about processes of care, and medical outcomes at 90 days after the index VTE event were abstracted from medical records. We used logistic regression to explore associations between race, processes of care, and the overall 90-day complication rate (i.e., death, bleeding, or recurrent VTE), adjusting for patient baseline characteristics. RESULTS: Multivariable analysis demonstrated that administration of warfarin within 1 day of starting heparin (odds ratio [OR] 0.20, 95% confidence interval [CI]: 0.05-0.42) and overlap of heparin and warfarin treatment >or=4 days (OR 0.09, 95% CI: 0.02-0.50) were associated with a lower complication rate, and African American race was associated with a higher complication rate (OR 5.2, 95% CI: 1.3-21.6). Race was not significantly associated with the performance of processes of care in multivariable analysis. CONCLUSION: Although African Americans had an increased risk of complications following VTE, race was not independently associated with the use of processes of care for VTE.
Authors: Neil A Zakai; Leslie A McClure; Suzanne E Judd; Monika M Safford; Aaron R Folsom; Pamela L Lutsey; Mary Cushman Journal: Circulation Date: 2014-02-07 Impact factor: 29.690
Authors: Neil A Goldenberg; John M Kittelson; Thomas C Abshire; Marc Bonaca; James F Casella; Rita A Dale; Jonathan L Halperin; Frances Hamblin; Craig M Kessler; Marilyn J Manco-Johnson; Robert F Sidonio; Alex C Spyropoulos; P Gabriel Steg; Alexander G G Turpie; Sam Schulman Journal: JAMA Date: 2022-01-11 Impact factor: 157.335
Authors: Nakela L Cook; Denise E Bonds; Catarina I Kiefe; Jeptha P Curtis; Harlan M Krumholz; Nancy R Kressin; Eric D Peterson Journal: Circ Cardiovasc Qual Outcomes Date: 2013-03-12
Authors: Drahomir Aujesky; David Jiménez; Maria K Mor; Ming Geng; Michael J Fine; Said A Ibrahim Journal: Circulation Date: 2009-02-09 Impact factor: 29.690
Authors: Anna K Stuck; Marie Méan; Andreas Limacher; Marc Righini; Kurt Jaeger; Hans-Jürg Beer; Joseph Osterwalder; Beat Frauchiger; Christian M Matter; Nils Kucher; Michael Egloff; Markus Aschwanden; Marc Husmann; Anne Angelillo-Scherrer; Nicolas Rodondi; Drahomir Aujesky Journal: PLoS One Date: 2014-07-01 Impact factor: 3.240
Authors: Charlène Insam; Marie Méan; Andreas Limacher; Anne Angelillo-Scherrer; Markus Aschwanden; Martin Banyai; Juerg-Hans Beer; Henri Bounameaux; Michael Egloff; Beat Frauchiger; Marc Husmann; Nils Kucher; Bernhard Lämmle; Christian Matter; Joseph Osterwalder; Marc Righini; Daniel Staub; Nicolas Rodondi; Drahomir Aujesky Journal: PLoS One Date: 2016-02-23 Impact factor: 3.240